Protocol
Replacing industrial trans fat
In controlled feeding trials, trans fatty acids raised LDL Low-density lipoprotein cholesterol, the cholesterol fraction most closely tied to plaque in the arteries. cholesterol and lowered HDL cholesterol compared with oleic acid, and a meta-analysis A study that pools the numbers from several trials into one combined estimate. of 60 trials found replacing trans fat improved the total-to-HDL cholesterol ratio about twice as much as replacing saturated fat.
At a glance
Trans fats are the fats made when vegetable oils are partly hardened, once common in margarine, frying fat and baked goods. In feeding trials they raised the cholesterol linked to heart disease and lowered the protective kind. No trial has counted heart attacks after taking them out of the diet.
- What was measured
- LDL and HDL cholesterol on controlled diets.
- How big
- LDL cholesterol was 0.37 mmol/L (14 mg/dL) higher on the trans fat diet than on the oleic acid diet.Read from the summary of PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 2374566.
- Who it applies to
- Healthy adults on controlled diets. No trial measured heart attacks.
- Safety
- None specific to removing trans fat.
- Compared with
- The same diet with oleic acid (olive-oil-type fat) instead.
- Certainty
- Grade B, resting on: Controlled feeding trial and a meta-analysis of 60 feeding trials.
- What would change this grade
- Could rise to A with: Randomized trial. Who: Adults. Measured: Cardiovascular events. Length: Several years.
- Cost
- No price recorded yet.
- Sources
- 2 studies cited on this record, listed under Sources.
- For clinicians
- A one-page summary of this record that prints with a clinician's name and practice, folds to a plain-language patient handout, and gives a chart note to paste into the patient record: Printable summary and chart note.
In controlled feeding trials, trans fatty acids raised LDL cholesterol and lowered HDL cholesterol compared with oleic acid, and a meta-analysis of 60 trials found replacing trans fat improved the total-to-HDL cholesterol ratio about twice as much as replacing saturated fat. No randomized trial has counted heart attacks after removing trans fat.
Why this letter
Why this gradeThe reasoning, and what the grade does not cover.
Grade B on LDL cholesterol. A controlled feeding trial found LDL 14 mg/dL higher and HDL 7 mg/dL lower on trans fatty acids than on oleic acid (Mensink and Katan, 1990; PMID 2374566), and a meta-analysis of 60 feeding trials confirmed that replacing trans fat improves the total-to-HDL cholesterol ratio more than replacing saturated fat (Mensink et al., 2003; PMID 12716665). LDL cholesterol is an established stand-in.
WHY NOT Ano randomized trial has counted heart attacks or deaths after removing trans fat.
WHAT THIS GRADE DOES NOT COVERnaturally occurring ruminant trans fat in dairy and meat, which these trials did not separate, and heart attacks or deaths, which no trial removing trans fat has counted.
A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →
Who responds: this record's trial reading reports no subgroup that identifies who responds.
Evidence notes: randomized trial, meta-analysis
Endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. graded: LDL and HDL cholesterol (surrogate)
Last reviewed: November 2026
The trial that would change this grade.
Positive trials of this shape from independent research groups would move this entry to A.
Why the current trials fall short
Trans fat has largely been removed from food supplies, so an outcome trial is unlikely.
ClinicalTrials.gov, the public registry run by the U.S. National Library of Medicine, lists studies that are recruiting volunteers. The link below searches it for Trans Fatty Acids among studies recruiting now. EBL has no relationship with any listed study and receives no payment for this link.
Search recruiting studies of Trans Fatty Acids on ClinicalTrials.gov
Dose, form and timing
Fasting LDL and HDL cholesterol.
As studiedDose, form, population and duration for every use.
A grade describes the intervention that was tested. Where the product on the shelf differs from it, this says so.
Safety
No safety data. Each caution on this record, sorted by what it rests on.
None recorded.
None recorded.
None recorded.
None recorded.
No safety data: EBL has found no trial or report of harm for this record. That is an absence of evidence, not a finding of safety.
Grade history
How this letter has changedLatest: No. 440 · November 2026 · First graded.
New record in the food section. In controlled feeding trials, trans fatty acids raised LDL cholesterol and lowered HDL cholesterol compared with oleic acid, and a meta-analysis of 60 trials found replacing trans fat improved the total-to-HDL cholesterol ratio about twice as much as replacing saturated fat. No randomized trial has counted heart attacks after removing trans fat.PMID 2374566 PMID 12716665
Every change to a letter on this site is dated and published. The full evidence log →
Sources
- Citations
- Every paper cited on this page is matched to its PubMed record on every build.
- Retractions
- None of these papers is retracted or under a journal expression of concern. PubMed is checked again on every build.
- Read against the papers
- November 2026. By a language model (AI-assisted reading), not yet reviewed by a clinician.
- Outside review
- Not yet done. No reviewer outside EBL has checked this record.
What each of these checks can and cannot show: evidence integrity.
The evidence, in fullTwo papers, each linked to its PubMed record.
Mensink and Katan (N Engl J Med, 1990; PMID 2374566): controlled feeding trial comparing diets rich in trans fatty acids, saturated fat and oleic acid; on the trans diet LDL was 0.37 mmol/L (14 mg/dL) higher and HDL 0.17 mmol/L (7 mg/dL) lower than on the oleic acid diet. Mensink et al. (Am J Clin Nutr, 2003; PMID 12716665): meta-analysis of 60 controlled trials; replacing trans fatty acids with carbohydrates and cis unsaturated fat lowered the total-to-HDL cholesterol ratio almost twice as much as replacing saturated fat.
How EBL searched for the trials (1 search)
The search that was run, what it returned, and what was left out and why, so the absence of evidence can be checked as well as its presence.
("trans fatty acid*"[tiab] OR "trans fat*"[tiab]) AND (LDL[tiab] OR cholesterol[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt])PubMed watch: does a new study change the grade? (nothing new)
No new paper matching the searches behind this grade has been added to PubMed since November 2026.
Last run November 2026. A letter on EBL moves only after a logged review. A new paper never moves a letter by arriving: it is read, the answer is written here, and any change to the letter is published in the evidence log.
For each trial behind a letter on this page, the funding its PubMed record lists. "No funder" means PubMed lists none, not that the trial had no funding.
- Mensink et al., 1990, N Engl J Med (PMID 2374566): PubMed lists no funder for this trial.
Disclosure
Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.
Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy
© Evidence Based Longevity, Inc. All rights reserved
These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.
Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →